Holmgaard, R. B., Zamarin, D., Lesokhin, A., Merghoub, T., & Wolchok, J. D. (2016). Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors. EBioMedicine.
Citação norma ChicagoHolmgaard, Rikke B., Dmitriy Zamarin, Alexander Lesokhin, Taha Merghoub, and Jedd D. Wolchok. "Targeting Myeloid-derived Suppressor Cells With Colony Stimulating Factor-1 Receptor Blockade Can Reverse Immune Resistance to Immunotherapy in Indoleamine 2,3-dioxygenase-expressing Tumors." EBioMedicine 2016.
Citação norma MLAHolmgaard, Rikke B., et al. "Targeting Myeloid-derived Suppressor Cells With Colony Stimulating Factor-1 Receptor Blockade Can Reverse Immune Resistance to Immunotherapy in Indoleamine 2,3-dioxygenase-expressing Tumors." EBioMedicine 2016.